Clinical Trials Directory

Trials / Completed

CompletedNCT01308112

Prenatal Iron and Malaria Study

A Randomised Trial to Assess the Safety and Efficacy or Iron Supplementation in Kenyan Pregnant Women

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
470 (actual)
Sponsor
London School of Hygiene and Tropical Medicine · Academic / Other
Sex
Female
Age
15 Years – 45 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to compare the presence of Plasmodium infection in parturient women who antenatally received a combination of iron-fortified foods with iron supplements versus iron-fortified foods only.

Detailed description

As per recommendations by the World Health Organization (WHO), iron supplementation in children should be restricted in malaria-endemic areas because of concerns that it can lead to an increased burden of malaria. Universal iron supplementation continues to be recommended, however, for women during pregnancy and 3 months postpartum. Observational studies have shown that iron deficiency in parturient women is associated with a marked reduction in the prevalence and density of malarial parasites in the placenta. Plasmodium infections in pregnant women have devastating effects on the foetus and neonate, causing low birth weight, intrauterine growth retardation, preterm delivery, spontaneous abortion, stillbirth and neonatal mortality. Based on our previous work, the Kenyan government is currently drafting legislation for mandatory iron fortification of industrially milled flour. Implementation of the new fortification policy means that pregnant women will receive iron through a combination of fortified foods and supplementation. The investigators are concerned about the safety of the high iron intake resulting from such a policy.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTironDaily supplementation with iron (60 mg) as ferrous sulphate

Timeline

Start date
2011-10-01
Primary completion
2013-04-01
Completion
2013-05-01
First posted
2011-03-03
Last updated
2013-05-29

Locations

1 site across 1 country: Kenya

Source: ClinicalTrials.gov record NCT01308112. Inclusion in this directory is not an endorsement.